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Abstract: Morphoea Profunda is a rare variant of Morphoea that presents clinically as a solitary fibrotic plaque. Morphoea Profunda 
presenting with atrophic lesions has rarely been reported in literature. We report the case of a 26 year old Nepalese lady who presented 
to us with multiple non-inflammatory atrophic lesions on her body without significant skin induration, pigmentation and texture change. 
The findings on histopathology confirmed a diagnosis of Morphoea Profunda. Hence, Morphoea Profunda should be considered in the 
differential diagnosis of anyone presenting with asymptomatic atrophy of the skin.
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Introduction
Morphoea is a localized type of scleroderma, which 
is a connective tissue disorder affecting the micro-
vasculature  and  loose  connective  tissue.1  The 
etiology of Morphoea is unknown but environmental 
exposures,  immune  alterations,  microchimerism 
with  autoimmunity,  trauma,  Borrelia  infection  and 
familial  predisposition  have  all  been  suggested  as 
contributing  to  the  pathogenesis  of  the  disease.2 
  Clinically Morphoea comprises of at least five   distinct 
types:  Morphoea  en  plaques,  Bullous    Morphoea, 
Linear  Morphoea,    Nodular  Morphoea  and  Deep 
Morphoea.3 Four different types of Deep   Morphoea 
have  been  distinguished:  Subcutaneous  Morphoea, 
Eosinophilic  Fasciitis,  Disabling  Pansclerotic 
  Morphoea and Morphoea Profunda.4
Here, we report an uncommon case of Morphoea 
Profunda (MP), a type of Morphoea rarely mentioned 
in the literature, presenting with multiple isolated non-
inflammatory atrophic lesions mimicking Localized 
Lipoatrophy.
case Report
A 26 year old female presented to us with asymptom-
atic atrophy of skin on multiple sites of her body since 
two years. It was first noticed on her anterior thighs 
followed in a few months by similar lesions gradu-
ally appearing on her buttocks, eventually appearing 
in her iliac region, back, left upper arm and her face 
within a year. She did not complain of pain, redness or 
itching on these areas. There was no history of trauma 
or any other skin lesions on those sites prior to this. 
There was no history of any systemic illness, neither 
a history of similar illness in her family. She was not 
under any medication.
On  examination,  there  were  multiple  atrophic 
areas on her right cheek, left upper arm, both anterior 
thighs, buttocks, sacral region and scalp (Figs. 1–4). 
The lesions varied in size from 2 × 3 cm to 8 × 10 cm 
with  ill-defined  margins.  The  skin  overlying  the 
lesions  showed  normal  color  without  any  obvious 
induration  or  tenderness.  Examination  of  the  sur-
rounding skin, hair, nails and other systems did not 
reveal any abnormality.
Her routine blood examination including hemo-
globin, blood counts, and hematocrit, ESR, random 
blood sugar, urea, creatinine, sodium, potassium and 
liver function tests were normal. Anti-nuclear anti-
bodies, Anti dsDNA and serologies for Syphilis and 
HIV were non reactive. Borrelia Serology was not 
done due to unavailability of laboratory facilities.
Histopathological examination of a punch biopsy 
taken from a lesion on the left upper arm showed kera-
tinized stratified squamous epithelium with increased 
basal pigmentation. Underlying papillary and reticu-
lar dermis showed thick and thin bands of   collagenous 
tissue. The dermal adnexal glands showed lack of 
adipocytes.  Subcutis  revealed  increased  collagen 
bands with diminished adipocytes. There was patchy 
mononuclear infiltrate in the subcutis. (Figs. 5 and 6). 
A diagnosis of Morphoea Profunda was made based 
on this typical histological appearance.5
The patient was started on oral Hydroxychloroquine 
200  mg  twice  a  day  and  a  follow  up  visit  was 
scheduled in 3 months. On follow-up, the lesions had 
been static without any changes. No new lesions were 
noted during this period. The patient was advised to 
continue with her medication and the need for regular 
follow up was emphasized. However, the patient was 
lost to follow-up thereafter.
Discussion
Scleroderma  is  a  chronic  disease  of  unknown 
  etiology that affects the microvasculature and loose 
connective  tissue.  It  is  characterized  clinically  by 
fibrous deposition and obliteration of vessels in the 
skin,  lungs,  gastrointestinal  tract,  kidneys  and  the 
heart.1 Scleroderma may be localized or generalized. 
  Localized types are: Morphoea en plaques, Bullous 
Morphoea, Linear Morphoea, Nodular Morphoea and 
Deep   Morphoea.3 A rare variant of Morphoea is Mor-
phoea Profunda, first described by Whittaker et al in 
1989 as a solitary fibrotic plaque.6
Patients with MP are usually middle aged with an 
approximately equal sex distribution. Most patients 
who are affected present with a single fibrotic plaque 
usually located over the back, shoulder and neck or 
paraspinal area involving the skin and deeper tissue.7
Our  patient  was  unusual  because  she  presented 
with deep atrophic lesions on multiple sites of her 
body without preceding inflammatory changes. Also, 
unlike the previous case reports of MP, the skin lesions 
showed no obvious changes in pigmentation, texture 
or induration. Such a presentation was similar to cases A rare case of Morphoea profunda presenting with atrophic skin lesions
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Figures 1–4. Ill defined atrophic lesions without induration, abnormal pigmentation, or signs of inflammation in right cheek, left arm, right scapula, buttock, 
and respectively.
Figures 5 and 6. punch biopsy of affected lesion showing hyalinization of the collagen bundles in the deep dermis and subcutaneous tissue associated 
with sparse inflammatory infiltrate that were suggestive of Morphoea Profunda in low power (Fig. 5) and high power (Fig. 6).Giri et al
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of Morphoea Profunda reported by Jablonska et. al. 
and more recently by Khelifa et al.8,9 However, in the 
former, the involvement was linear and band like and 
there was involvement of muscles as opposed to our 
patient. In the latter, there were multiple asymptom-
atic atrophic lesions in the left arm of a 53 year old 
woman as opposed to more widespread lesions in our 
patient.
The histopathological changes in MP are different 
from widespread Morphoea because the former have 
deeper  involvement  and  more  pronounced  inflam-
matory infiltrates. Also the collagen in the reticular 
dermis  and  subcutis  are  hyalinized  and  sclerotic.8 
  Histopathologically, collagen deposits in the dermis 
and the subcutis, atrophy of the appendages, dimin-
ished adipocytes along with an inflammatory cellular 
infiltrate are considered pathognomonic of Morphoea; 
all of which was present in our case.
The cause of Morphoea is unknown. Studies have 
shown abnormalities in fibroblasts from patients with 
Morphoea including increased expression of a number 
of growth factors and their receptors.7 Other factors 
that have been implicated in the etiology are infec-
tion with Borrelia, genetic susceptibility, trauma and 
drugs  including  Bromocriptine  and  L-tryptophan.2 
Our  patient  did  not  have  an  obvious  precipitating 
factor. However, Borrelia serology could not be done 
due to unavailability of laboratory facilities.
Morphoea Profunda should be differentiated from 
Eosinophilic Fasciitis and Atrophoderma of Pasini and 
Pierini. These diagnoses were ruled out based on the 
histopathological and clinical findings.   Eosinophilic 
Fascitis clinically presents as edema, skin induration 
with a “peau d’orange” appearance which was not 
present  in  our  case.10 Atrophoderma  of  Pasini  and 
Pierini was differentiated based on histopathological 
findings, as sclerosis was more prominent in our case. 
However, the two conditions can be regarded as a 
spectrum of the same disease process;   Atrophoderma 
being a more abortive form of the atrophic process 
resulting  in  Morphoea.11  Clinically  two  different 
  conditions: Localized Involutional Lipoatrophy (LIL) 
and  lipoatrophic  scars  of  Lupus  Panniculitis,  can 
present with deep atrophic lesions similar to our case. 
  However, in the former, the lesions are usually solitary 
and hypopigmented as opposed to multiple lesions 
and normal skin color in our case. Histologically in 
LIL, there are small attenuated fat lobules composed 
of small adipocytes embedded in a well vascularized 
and hyalinized background.12 These conditions were 
ruled out on the basis of histopathological findings.
We conclude that Morphoea Profunda can rarely 
present as deep atrophic lesions of the skin without 
preceding inflammatory changes in the skin as seen 
in typical cases. It can mimic Localized Involutional 
Lipoatrophy and other causes of deep atrophic lesions 
of the skin. Hence, it should be considered as one of 
the  differential  diagnosis  in  any  patient  presenting 
with deep atrophic lesions of the skin.
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Figures  1–4  as  a  multi-panel  photograph,  and 
  Figures  5  and  6  separately  as  another  multi-panel 
  photograph as JPG files.
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